A ‘burgeoning black market’, inflated dosing and the over-judicialization of health care: reporters around the world tell stories about Keytruda

In a yearlong investigation led by the International Consortium of Investigative Journalists, reporters from more than 37 countries found the cancer drug’s high price impacts patients and health systems differently. Source: ICIJ